Home » Topics » Regulatory

Regulatory
RSS

Rogaine Extra Strength for Men recommended for approval as OTC

July 21, 1997

FDA clears new indication and new labeling for Zoloft

July 18, 1997

Ganciclovir implant effective in treating CMV retinitis

July 17, 1997

RPR launches room-temperature formulation of DDAVP

July 16, 1997

Athena Neurosciences and Wyeth-Ayerst copromote Naprelan

July 16, 1997

RiboGene signs marketing agreement for intranasal metoclopramide

July 16, 1997

Mianserin studied for treatment of sexual dysfunction

July 16, 1997

Bigmar submits ANDA for leucovorin

July 15, 1997

Teva receives FDA approval for generic estazolam

July 15, 1997

FDA approves antibacterial generic from Mylan

July 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
In 2025, science’s biggest story was political
BioWorld
In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
FDA says yes to Cytokinetics’ aficamten, now Myqorzo, in oHCM
BioWorld
Cytokinetics Inc. scored U.S. FDA marketing clearance Dec. 19 for Myqorzo (aficamten) 5-mg, 10-mg, 15-mg, and 20-mg tablets to improve functional capacity and...
Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis
BioWorld Science
Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....